These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9246218)

  • 21. [Association of 5-HT(2A) receptor polymorphism and attention deficit hyperactivity disorder in children].
    Li J; Wang Y; Qian Q; Wang B; Zhou R
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1173-6. PubMed ID: 12475403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between SNAP-25 gene polymorphism and attention deficit hyperactivity disorder].
    Zhang HY; Zhu YB; Chang H; Chen JC
    Zhonghua Er Ke Za Zhi; 2008 Aug; 46(8):564-9. PubMed ID: 19099826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW; Kim BN; Cho SC
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms.
    Aureli A; Del Beato T; Sebastiani P; Marimpietri A; Melillo CV; Sechi E; Di Loreto S
    Int J Immunopathol Pharmacol; 2010; 23(3):873-80. PubMed ID: 20943059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association study of GIT1 gene with attention-deficit hyperactivity disorder in Brazilian children and adolescents.
    Salatino-Oliveira A; Genro JP; Chazan R; Zeni C; Schmitz M; Polanczyk G; Roman T; Rohde LA; Hutz MH
    Genes Brain Behav; 2012 Oct; 11(7):864-8. PubMed ID: 22897819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder.
    Kustanovich V; Merriman B; McGough J; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2003 Mar; 8(3):309-15. PubMed ID: 12660803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
    Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and functional characterisation of a novel dopamine beta hydroxylase gene variant associated with attention deficit hyperactivity disorder.
    Tong J; McKinley LA; Cummins TD; Johnson B; Matthews N; Vance A; Heussler H; Gill M; Kent L; Bellgrove MA; Hawi Z
    World J Biol Psychiatry; 2015; 16(8):610-8. PubMed ID: 25975715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity.
    Bergman O; Westberg L; Lichtenstein P; Eriksson E; Larsson H
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1367-76. PubMed ID: 21466746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parental smoking during pregnancy and ADHD in children: the Danish national birth cohort.
    Zhu JL; Olsen J; Liew Z; Li J; Niclasen J; Obel C
    Pediatrics; 2014 Aug; 134(2):e382-8. PubMed ID: 25049343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree.
    Lesch KP; Selch S; Renner TJ; Jacob C; Nguyen TT; Hahn T; Romanos M; Walitza S; Shoichet S; Dempfle A; Heine M; Boreatti-Hümmer A; Romanos J; Gross-Lesch S; Zerlaut H; Wultsch T; Heinzel S; Fassnacht M; Fallgatter A; Allolio B; Schäfer H; Warnke A; Reif A; Ropers HH; Ullmann R
    Mol Psychiatry; 2011 May; 16(5):491-503. PubMed ID: 20308990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association analysis of dopamine D4 receptor gene polymorphism and attention deficit hyperactivity disorder with/without disruptive behavior disorder].
    Guan LL; Wang YF; Li J; Wang B; Yang L; Qian QJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):233-6. PubMed ID: 17572775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder with or without learning disorder].
    Li J; Wang YF; Zhou RL; Yang L; Zhang HB; Wang B
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2114-8. PubMed ID: 14720417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association between serotonin 1D gene polymorphisms and attention deficit hyperactivity disorder comorbid or not comorbid learning disorder].
    Li J; Wang Yf; Zhou RL; Yang L; Zhang HB; Wang B
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):535-8. PubMed ID: 17940576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No evidence for an association between the T102C and 1438 G/A polymorphisms of the serotonin 2A receptor gene in attention deficit/hyperactivity disorder in a Turkish population.
    Zoroglu SS; Erdal ME; Erdal N; Ozen S; Alasehirli B; Sivasli E
    Neuropsychobiology; 2003; 47(1):17-20. PubMed ID: 12606840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of DRD2 gene and ADHD.
    Serý O; Drtílková I; Theiner P; Pitelová R; Staif R; Znojil V; Lochman J; Didden W
    Neuro Endocrinol Lett; 2006; 27(1-2):236-40. PubMed ID: 16648784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic system genes in ADHD: toward a biological hypothesis.
    Kirley A; Hawi Z; Daly G; McCarron M; Mullins C; Millar N; Waldman I; Fitzgerald M; Gill M
    Neuropsychopharmacology; 2002 Oct; 27(4):607-19. PubMed ID: 12377397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain Correlates of the Interaction Between 5-HTTLPR and Psychosocial Stress Mediating Attention Deficit Hyperactivity Disorder Severity.
    van der Meer D; Hoekstra PJ; Zwiers M; Mennes M; Schweren LJ; Franke B; Heslenfeld DJ; Oosterlaan J; Faraone SV; Buitelaar JK; Hartman CA
    Am J Psychiatry; 2015 Aug; 172(8):768-75. PubMed ID: 25998280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the calcyon gene (DRD1IP) with attention deficit/hyperactivity disorder.
    Laurin N; Misener VL; Crosbie J; Ickowicz A; Pathare T; Roberts W; Malone M; Tannock R; Schachar R; Kennedy JL; Barr CL
    Mol Psychiatry; 2005 Dec; 10(12):1117-25. PubMed ID: 16172615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor).
    Johann M; Bobbe G; Putzhammer A; Wodarz N
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1527-34. PubMed ID: 14574222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.